Nexgel Inc
NASDAQ:NXGL

Watchlist Manager
Nexgel Inc Logo
Nexgel Inc
NASDAQ:NXGL
Watchlist
Price: 4.73 USD 2.38% Market Closed
Market Cap: 35.6m USD
Have any thoughts about
Nexgel Inc?
Write Note

Nexgel Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nexgel Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Nexgel Inc
NASDAQ:NXGL
Revenue
$4.1m
CAGR 3-Years
83%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Revenue
$1.4B
CAGR 3-Years
13%
CAGR 5-Years
7%
CAGR 10-Years
4%
ICU Medical Inc
NASDAQ:ICUI
Revenue
$2.3B
CAGR 3-Years
22%
CAGR 5-Years
13%
CAGR 10-Years
23%
Align Technology Inc
NASDAQ:ALGN
Revenue
$4B
CAGR 3-Years
2%
CAGR 5-Years
12%
CAGR 10-Years
18%
Lantheus Holdings Inc
NASDAQ:LNTH
Revenue
$1.5B
CAGR 3-Years
57%
CAGR 5-Years
34%
CAGR 10-Years
18%
Merit Medical Systems Inc
NASDAQ:MMSI
Revenue
$1.3B
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
10%
No Stocks Found

Nexgel Inc
Revenue Breakdown

Breakdown by Geography
Nexgel Inc

Not Available

Breakdown by Segments
Nexgel Inc

Total Revenue: 4.1m USD
100%
Contract Manufacturing: 2.7m USD
67.2%
Branded Consumer Products: 1.2m USD
30.4%
Other Incomes: 84k USD
2.1%
Custom And White Label Finished Goods: 15k USD
0.4%
Show More
Show Less

Nexgel Inc
Glance View

Market Cap
35.6m USD
Industry
Health Care

NexGel, Inc. engages in the manufacture of polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Langhorne, Pennsylvania. The company went IPO on 2021-12-22. The firm is engaged in the manufactures of high-water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. The firm specializes in custom gels by capitalizing on manufacturing technologies. Its products are manufactured by using proprietary and non-proprietary mixing, coating and cross-linking technologies. The company operates as a contract manufacturer of aqueous polymer hydrogels. The company delivers medication through hydrogel patches. Its Hydrogel patches are used for transdermal applications, such as hormone replacement therapy and contraception, treatment of acne, shingles, diabetes, motion sickness, treatment of angina with nitroglycerin and treatment of smoking addiction.

NXGL Intrinsic Value
7.73 USD
Undervaluation 39%
Intrinsic Value
Price

See Also

What is Nexgel Inc's Revenue?
Revenue
4.1m USD

Based on the financial report for Dec 31, 2023, Nexgel Inc's Revenue amounts to 4.1m USD.

What is Nexgel Inc's Revenue growth rate?
Revenue CAGR 5Y
13%

Over the last year, the Revenue growth was 99%. The average annual Revenue growth rates for Nexgel Inc have been 83% over the past three years , 13% over the past five years .

Back to Top